Ravulizumab

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Ravulizumab and local guidelines before prescribing.

Complement inhibitor

Mechanism

Long-acting complement C5 inhibitor.

Uses

Paroxysmal nocturnal haemoglobinuria, atypical HUS, myasthenia gravis.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Meningococcal infection, headache, infusion reactions.

Interactions

Few.

Contraindications and cautions

Unresolved meningococcal infection

Monitoring

Infection signs

Pregnancy and breastfeeding

Avoid unless essential

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

Meningococcal vaccination and antibiotic prophylaxis; alert card.

More from the textbook: uses, cautions and other points
Where it is discussed in the book